Delving into the Latest Updates on Novel erythropoiesis stimulant(Shanghai Qiangbang Biological Technology Co Ltd) with Synapse

Overview

Drug Type

Colony-stimulating factors

Synonyms-

Target

Mechanism

EPO receptor agonists(Erythropoietin receptor agonists), Erythropoiesis stimulants(Erythropoiesis stimulants)

Therapeutic Areas

Active Indication

Inactive Indication-

Originator Organization

Active Organization

Inactive Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Anemia	Phase 1	CN	Suzhou Shengji Pharmaceutical Co Ltd	-
Anemia	Phase 1	CN	Suzhou Kangju BIOTECHNOLOGY Co., Ltd.	-
Anemia	Phase 1	CN	Shanghai Qiangbang Biological Technology Co., Ltd.	-

Login to view more data

Indication

Phase

Evaluation

View All Results

Study	Phase	Population	Analyzed Enrollment	Group	Results	Evaluation	Publication Date


EHA2022	Not Applicable	Myelodysplastic Syndromes	183	Erythropoiesis stimulating agents (ESAs)	(nomfodzemu) = tuzntstgso glwhyzoczz (unzfeoqfys )	-	10 Jun 2022
EHA2015	Not Applicable	Myelodysplastic Syndromes	137	Erythropoiesis stimulating agents (ESAs)	(chswxhwyvi) = mnxwwoxsme ybtsfyjjkh (bryebxypxb ) View more	-	21 May 2015
ASCO2014	Not Applicable	Neoplasms	-	erythropoiesis stimulating agents (ESA) (Oncology Analytics (OA) cancer care quality initiative)	ehyeyiijbg(bcqfmuwvns) = bfcnosugfz jklyddchdv (euuoknrtyt )	Positive	20 May 2014
ASCO2012	Not Applicable	Ovarian Cancer Second line	-	erythropoiesis-stimulating agents (Patients after APPRISE mandate)	eoxuozbaky(yhxapbezqx) = bhtozzbbeq witkhscmwl (thnwsbxpie )	Positive	20 May 2012
ASCO2012	Not Applicable	Ovarian Cancer Second line	-	erythropoiesis-stimulating agents (Patients before APPRISE mandate)	eoxuozbaky(yhxapbezqx) = tdmjpegrrr witkhscmwl (thnwsbxpie )	Positive	20 May 2012